Australia Adopts Black Triangle Marking for New Drugs

Australian drug regulators approved the black-triangle marking system for products subject to heightened monitoring for side effects.

Starting in January, the inverted triangle symbol and accompanying text will appear on packaging and inserts for most newly approved branded drugs and for some with newly approved supplemental indications.

The system, which mirrors a similar EU program, is designed to foster reporting of side effects, which may not have shown up in clinical trials.